-
公开(公告)号:US09556436B2
公开(公告)日:2017-01-31
申请号:US14747041
申请日:2015-06-23
发明人: Shin-Ru Shih , Chi-Jene Chen , Sheng-Yu Huang
IPC分类号: C12N15/11 , C12N15/113 , C12Q1/70
CPC分类号: C12N15/1131 , C12N15/113 , C12N2310/113 , C12N2310/141 , C12N2310/315 , C12N2310/321 , C12N2310/3521 , C12N2320/30 , C12Q1/6883 , C12Q2600/158 , C12Q2600/178
摘要: A method of treating Influenza A is disclosed. The method includes the step of administering a pharmaceutical composition including an oligonucleotide complementary to a corresponding segment of the nucleotide sequence of microRNA-1290 (miR-1290) (SEQ ID NO: 1) to a subject suffering from Influenza A, wherein at least one of the nucleotides in the oligonucleotide is Thymidine phosphate.
摘要翻译: 公开了治疗流感A的方法。 该方法包括给予患有甲型流感的受试者的包含与微小RNA-1290(miR-1290)(SEQ ID NO:1)的核苷酸序列的相应片段互补的寡核苷酸的药物组合物给药的步骤,其中至少一种 寡核苷酸中的核苷酸是磷酸胸苷。
-
公开(公告)号:US11679102B2
公开(公告)日:2023-06-20
申请号:US17333117
申请日:2021-05-28
发明人: Shin-Ru Shih , Yu-An Kung , Huan-Jung Chiang , Chuan-Tien Hung , Yu-Nong Gong , Hsin-Ping Chiu , Chiung-Guei Huang , Peng-Nien Huang , Sheng-Yu Huang
IPC分类号: A61P31/16 , A61K31/4436 , A61K31/131 , A61K31/245 , A61K31/427 , A61K31/4439 , A61K31/499 , A61K9/00
CPC分类号: A61K31/4436 , A61K9/0053 , A61K31/131 , A61K31/245 , A61K31/427 , A61K31/4439 , A61K31/499 , A61P31/16
摘要: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20210386702A1
公开(公告)日:2021-12-16
申请号:US17333117
申请日:2021-05-28
发明人: Shin-Ru Shih , Yu-An Kung , Huan-Jung Chiang , Chuan-Tien Hung , Yu-Nong Gong , Hsin-Ping Chiu , Chiung-Guei Huang , Peng-Nien Huang , Sheng-Yu Huang
IPC分类号: A61K31/245 , A61K31/427 , A61K31/131 , A61K31/499
摘要: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20160376597A1
公开(公告)日:2016-12-29
申请号:US14747041
申请日:2015-06-23
发明人: Shin-Ru Shih , Chi-Jene Chen , Sheng-Yu Huang
IPC分类号: C12N15/113 , C12Q1/70
CPC分类号: C12N15/1131 , C12N15/113 , C12N2310/113 , C12N2310/141 , C12N2310/315 , C12N2310/321 , C12N2310/3521 , C12N2320/30 , C12Q1/6883 , C12Q2600/158 , C12Q2600/178
摘要: A method of treating Influenza A is disclosed. The method includes the step of administering a pharmaceutical composition including an oligonucleotide complementary to a corresponding segment of the nucleotide sequence of microRNA-1290 (miR-1290) (SEQ ID NO: 1) to a subject suffering from Influenza A, wherein at least one of the nucleotides in the oligonucleotide is Thymidine phosphate.
摘要翻译: 公开了治疗流感A的方法。 该方法包括给予患有甲型流感的受试者的包含与微小RNA-1290(miR-1290)(SEQ ID NO:1)的核苷酸序列的相应片段互补的寡核苷酸的药物组合物给药的步骤,其中至少一种 寡核苷酸中的核苷酸是磷酸胸苷。
-
-
-